Rivasur zweimal wöchentlich 9,5 mg/24 Stunden, Transdermales Pflaster
7680688970067
N06DA03
01.99.0.
1 / 3
google
Details
- Product number
- 6889702
- CPT
- -
- Packaging group
- 8
- Unit
- Pflaster
- Composition
- I) (Transdermales Pflaster): rivastigminum 51.84 mg, E 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, Trägermaterial: poly(ethylenis terephthalas), polyethylenum, Drucktinte: Blau, ad praeparationem pro 21.6 cm², cum liberatione 9.5 mg/24h. II) (Abdeckpflaster): acrylates et vinylis acetatis polymerisatum, Trägermaterial: polyesterum, ad praeparationem pro 46.7 cm².
Articles (1)
Rivasur zweimal wöchentlich 9,5 mg/24 Stunden, Transdermales Pflaster
Transdermales Pflaster
8
V2 data not available
Additional information from the official Swissmedic V2 database is not available for this product.